News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,773 Results
Type
Article (2473)
Company Profile (39)
Press Release (36261)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14141)
Career Advice (79)
Deals (2084)
Drug Delivery (9)
Drug Development (4112)
Employer Resources (10)
FDA (432)
Job Trends (770)
News (20169)
Policy (1053)
Tag
Academia (144)
Allergies (7)
Alliances (3489)
ALS (4)
Alzheimer's disease (50)
Antibody-drug conjugate (ADC) (20)
Approvals (433)
Artificial intelligence (15)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (475)
BIOSECURE Act (2)
Biosimilars (13)
Biotechnology (29)
Bladder cancer (7)
Brain cancer (5)
Breast cancer (24)
Cancer (186)
Cardiovascular disease (5)
Career advice (64)
Career pathing (1)
CAR-T (19)
Cell therapy (55)
Cervical cancer (2)
Clinical research (3246)
Collaboration (120)
Company closure (1)
Compensation (62)
COVID-19 (181)
CRISPR (9)
C-suite (41)
Cystic fibrosis (3)
Data (178)
Denatured (3)
Depression (7)
Diabetes (13)
Diagnostics (470)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (8)
Duchenne muscular dystrophy (17)
Earnings (4315)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6151)
Executive appointments (116)
FDA (496)
Funding (99)
Gene editing (18)
Gene therapy (26)
GLP-1 (61)
Government (149)
Guidances (8)
Healthcare (705)
Huntington's disease (4)
IgA nephropathy (7)
Immunology and inflammation (23)
Immuno-oncology (3)
Indications (3)
Infectious disease (188)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (6)
Intellectual property (13)
Interviews (7)
IPO (1000)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (6)
Labor market (6)
Layoffs (41)
Leadership (1)
Legal (213)
Liver cancer (6)
Lung cancer (19)
Lymphoma (5)
Management (4)
Manufacturing (24)
MASH (5)
Medical device (308)
Medtech (308)
Mergers & acquisitions (1171)
Metabolic disorders (40)
Multiple sclerosis (12)
Neurodegenerative disease (14)
Neuropsychiatric disorders (4)
Neuroscience (113)
NextGen: Class of 2025 (352)
Non-profit (153)
Now hiring (7)
Obesity (18)
Opinion (15)
Ovarian cancer (12)
Pain (13)
Pancreatic cancer (9)
Parkinson's disease (7)
Partnered (2)
Patents (27)
Patient recruitment (6)
Peanut (1)
People (5718)
Pharmaceutical (5)
Phase I (1399)
Phase II (1620)
Phase III (864)
Pipeline (121)
Policy (14)
Postmarket research (30)
Preclinical (610)
Press Release (2)
Prostate cancer (4)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (28)
Real estate (421)
Recruiting (5)
Regulatory (818)
Reports (7)
Research institute (142)
Resumes & cover letters (9)
RNA editing (2)
Schizophrenia (15)
Series A (30)
Series B (10)
Service/supplier (2)
Sickle cell disease (1)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (493)
Stomach cancer (2)
Supply chain (4)
The Weekly (1)
Vaccines (31)
Venture capital (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Today (6)
Last 7 days (21)
Last 30 days (160)
Last 365 days (2412)
2025 (1334)
2024 (2610)
2023 (2858)
2022 (3750)
2021 (4048)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (43)
Alabama (2)
Arizona (16)
Asia (1893)
Australia (300)
California (1081)
Canada (168)
China (48)
Colorado (25)
Connecticut (11)
Delaware (4)
Europe (3881)
Florida (48)
Georgia (9)
Hawaii (1)
Idaho (3)
Illinois (16)
India (1)
Indiana (38)
Japan (11)
Kansas (12)
Kentucky (1)
Maryland (31)
Massachusetts (375)
Michigan (11)
Minnesota (17)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (89)
New York (59)
North Carolina (101)
Northern California (467)
Ohio (29)
Oklahoma (2)
Oregon (5)
Pennsylvania (67)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (452)
Tennessee (3)
Texas (95)
United States (2179)
Utah (3)
Virginia (7)
Washington D.C. (1)
Washington State (63)
West Virginia (1)
Wisconsin (6)
38,773 Results for "ideaya biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IDEAYA Biosciences to Participate in Upcoming June 2025 Investor Relations Events
June 2, 2025
·
2 min read
Press Releases
IDEAYA Biosciences to Participate in Upcoming May 2025 Investor Relations Events
April 28, 2025
·
2 min read
Press Releases
IDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
May 6, 2025
·
14 min read
Press Releases
IDEAYA Biosciences Announces Participation in Upcoming April 2025 Investor Relations Events
April 1, 2025
·
2 min read
Press Releases
IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation for Darovasertib Monotherapy in Neoadjuvant Uveal Melanoma
March 31, 2025
·
5 min read
Press Releases
IDEAYA Biosciences Announces Phase 1/2 Expansion for IDE397 and Trodelvy® Combination in MTAP-Deletion Urothelial Cancer
April 10, 2025
·
4 min read
Press Releases
IDEAYA Biosciences to Participate in Upcoming February 2025 Investor Relations Events
January 27, 2025
·
2 min read
Press Releases
IDEAYA Biosciences Announces US FDA IND-Clearance for IDE849, a Potential First-in-Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors
May 6, 2025
·
5 min read
Press Releases
IDEAYA Biosciences Announces Successful FDA Type D Meeting on Phase 3 Registrational Trial Design for Darovasertib as Neoadjuvant Therapy for Primary Uveal Melanoma
April 14, 2025
·
6 min read
Biotech Bay
IDEAYA Biosciences to Participate in Upcoming June 2024 Investor Relations Events
IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in the upcoming investor relations events.
May 29, 2024
·
2 min read
1 of 3,878
Next
